SELL and neoplasm: One of the most relevant mechanisms of heparin inhibition of hematogenous spread of malignant cells appears to be via inhibition of P-selectin mediated platelet adhesion to tumor cells [50] and l-selectin mediated leukocyte interaction with tumor cells [51].